Published in Am J Pathol on March 01, 2001
Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol (2007) 1.85
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol (2001) 1.67
Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell (2003) 1.67
Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol (2002) 1.62
Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res (2005) 1.39
Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med (2008) 1.31
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer (2002) 1.19
Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. Br J Cancer (2004) 1.17
E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol (2007) 1.17
The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol (2009) 1.05
Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J (2005) 1.02
Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One (2012) 1.00
CD99 acts as an oncosuppressor in osteosarcoma. Mol Biol Cell (2006) 1.00
Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histol (2009) 0.99
Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas. BMC Cancer (2014) 0.98
Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J (2007) 0.96
Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases. Am J Pathol (2005) 0.95
Characterization of G2L3 (GAS2-like 3), a new microtubule- and actin-binding protein related to spectraplakins. J Biol Chem (2011) 0.94
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol (2009) 0.92
Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma. Oncologist (2010) 0.92
Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res (2011) 0.91
Caveolin-1 induces formation of membrane tubules that sense actomyosin tension and are inhibited by polymerase I and transcript release factor/cavin-1. Mol Biol Cell (2010) 0.90
Caveolin-1 in sarcomas: friend or foe? Oncotarget (2011) 0.90
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Oncotarget (2014) 0.88
Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma. PLoS One (2014) 0.87
Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer (2002) 0.86
Caveolin 1 protein expression in renal cell carcinoma predicts survival. BMC Urol (2011) 0.85
Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. Virchows Arch (2008) 0.85
Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joining. PLoS One (2010) 0.83
Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread? Clin Exp Metastasis (2012) 0.82
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma. PLoS One (2014) 0.81
MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice. Exp Mol Pathol (2010) 0.81
Overexpression of caveolin-1 in lymphoblastoid TK6 cells enhances proliferation after irradiation with clinically relevant doses. Strahlenther Onkol (2010) 0.80
Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract. J Korean Med Sci (2008) 0.79
Association of Caveolin-1 polymorphisms with colorectal cancer susceptibility in Taiwan. World J Gastrointest Oncol (2010) 0.78
Lesser-Known Molecules in Ovarian Carcinogenesis. Biomed Res Int (2015) 0.78
Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes. Front Immunol (2014) 0.78
The traditional Tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration. BMC Complement Altern Med (2015) 0.77
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. Oncotarget (2014) 0.76
Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation. Compr Physiol (2011) 0.75
Caveolin-1 is overexpressed in hypopharyngeal squamous cell carcinoma and correlates with clinical parameters. Oncol Lett (2016) 0.75
Immunohistochemical characteristics of basal-like breast cancer. Contemp Oncol (Pozn) (2017) 0.75
Uterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2. Endocrinology (2011) 0.75
Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma. Exp Ther Med (2017) 0.75
A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem (1973) 31.32
Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem (1998) 6.26
Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol (1994) 5.29
Caveolae and caveolins. Curr Opin Cell Biol (1996) 3.25
Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A (1995) 3.03
Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem (1989) 2.86
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene (1998) 2.59
Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A (1991) 2.43
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem (1997) 2.34
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J (1998) 2.23
Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci (1988) 2.16
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res (1999) 1.95
Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell (1987) 1.58
beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol (1999) 1.55
Crowded little caves: structure and function of caveolae. Cell Signal (1998) 1.49
Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett (1998) 1.47
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A (1994) 1.24
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene (2000) 1.22
Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene (1997) 1.17
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene (1999) 1.16
Caveolin-1 modulates the activity of the volume-regulated chloride channel. J Physiol (1999) 1.06
A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res (1998) 1.03
Caveolin-1 isoforms are encoded by distinct mRNAs. Identification Of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett (2000) 1.02
Molecular pathology of soft tissue and bone tumors. A review. Arch Pathol Lab Med (1999) 0.98
TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell (1996) 8.03
Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell (1993) 6.44
Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer (1977) 4.53
Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 4.41
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature (1988) 4.41
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem (1992) 3.54
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res (2001) 3.23
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med (1997) 2.88
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer (2008) 2.67
Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood (1990) 2.54
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol (2004) 2.45
Acute right-sided heart failure due to hemorrhage into a pericardial cyst. Ann Thorac Surg (1997) 2.24
Palliative endoscopic therapy of rectal carcinoma. Eur J Cancer (1996) 2.22
European and US publications in the 50 highest ranking pathology journals from 2000 to 2006. J Clin Pathol (2007) 2.20
Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci U S A (1997) 2.15
A genome-wide survey of RAS transformation targets. Nat Genet (2000) 2.06
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem (1986) 2.04
Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest (1996) 2.00
Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res (1997) 1.89
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology (2000) 1.82
Assessment of the size, position, and optical properties of breast tumors in vivo by noninvasive optical methods. Appl Opt (1998) 1.76
HEAT repeats mediate plasma membrane localization of Tor2p in yeast. J Biol Chem (2000) 1.75
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys (1995) 1.75
Treatment of oesophageal anastomotic leaks by temporary stenting with self-expanding plastic stents. Br J Surg (2009) 1.74
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila. Rheumatol Int (2003) 1.74
Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg (2006) 1.71
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol (2001) 1.67
Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer (2000) 1.65
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis (1989) 1.64
Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol (2001) 1.62
Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med (2000) 1.61
Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene (1997) 1.61
Subcutaneous crystal-storing histiocytosis associated with lymphoplasmacytic lymphoma (immunocytoma) Pathol Res Pract (1996) 1.57
Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg (2001) 1.55
Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology (2000) 1.55
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol (2001) 1.51
Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer (2003) 1.49
First spinal axis segment irradiation with spot-scanning proton beam delivered in the treatment of a lumbar primitive neuroectodermal tumour. Case report and review of the literature. Clin Oncol (R Coll Radiol) (2004) 1.49
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst (1999) 1.46
Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO) Eur J Cancer (1998) 1.45
Telemicroscopy via the internet. Nature (1998) 1.44
[Lymphatic mapping and sentinel lymph node biopsy in gastric cancer]. Chirurg (2003) 1.44
Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer (1997) 1.44
[Inter-disciplinary European guidelines on surgery of severe obesity]. Vnitr Lek (2008) 1.42
Three-dimensional endoluminal ultrasound: a new method for the evaluation of gastrointestinal tumors. Abdom Imaging (1999) 1.42
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer (2008) 1.41
Negative absolute temperature for motional degrees of freedom. Science (2013) 1.41
Primary hypothyroidism, central diabetes insipidus and growth hormone deficiency in multisystem Langerhans cell histiocytosis: a case report. Acta Paediatr (1998) 1.40
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer (2004) 1.39
The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients. Eur J Surg Oncol (2007) 1.39
Two-dimensional gel protein database of Saccharomyces cerevisiae (update 1999). Electrophoresis (1999) 1.39
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38
Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer (2000) 1.38
Prenatal diagnosis of the Wolf-Parkinson-White-syndrome by fetal magnetocardiography. BJOG (2001) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology (2000) 1.36
Count and density of human retinal photoreceptors. Graefes Arch Clin Exp Ophthalmol (1992) 1.35
Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart (1999) 1.33
Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer (1975) 1.33
Scoliosis and congenital anomalies associated with Klippel-Feil syndrome types I-III. Spine (Phila Pa 1976) (1997) 1.31
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol (2001) 1.31
Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis (1999) 1.30
Expression of AGR2 in non small cell lung cancer. Histol Histopathol (2007) 1.26
Development of a time-domain optical mammograph and first in vivo applications. Appl Opt (1999) 1.25
Retinal photoreceptor count, retinal surface area, and optic disc size in normal human eyes. Ophthalmology (1994) 1.23
Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med (1990) 1.20
Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience (1995) 1.19
MicroRNA expression profiles of trophoblastic cells. Placenta (2012) 1.18
HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer (2009) 1.17
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol (2006) 1.17
A haemorrhagic fever from the Côte d'Ivoire. Lancet (1999) 1.17
Genomic alterations associated with malignancy in head and neck cancer. Head Neck (1998) 1.17
Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology (1996) 1.16
Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer (1997) 1.16
Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol (1999) 1.14
Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res (1996) 1.14
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. Pathologe (2010) 1.14
Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis (2000) 1.14
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Ann Oncol (2014) 1.13
Different effects of nabilone and cannabidiol on binocular depth inversion in Man. Pharmacol Biochem Behav (2000) 1.13
[Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT)]. Z Orthop Ihre Grenzgeb (2004) 1.13
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene (2006) 1.13
A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene (1996) 1.12